Immediate Impact
53 standout
Citing Papers
Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
Towards targeting the breast cancer immune microenvironment
2024 Standout
Works of Mitchell Garrison being referenced
Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer—A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib
2018
A Phase I and pharmocokinetic study of exatecan mesylate administered as a protracted 21-day infusion in patients with advanced solid malignancies.
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mitchell Garrison | 98 | 34 | 18 | 56 | 12 | 160 | |
| Laura Biernat | 132 | 9 | 18 | 75 | 11 | 219 | |
| Wenhui Wu | 105 | 35 | 48 | 87 | 14 | 179 | |
| Jesús García‐Cano | 66 | 22 | 34 | 173 | 10 | 244 | |
| Ahmed El Bastawisy | 77 | 17 | 50 | 96 | 16 | 197 | |
| Nunzia Matrone | 89 | 32 | 34 | 103 | 11 | 194 | |
| Yan Sun | 89 | 16 | 14 | 63 | 10 | 180 | |
| Anne E. Theron | 60 | 9 | 14 | 128 | 9 | 248 | |
| Mark Yan | 95 | 59 | 7 | 33 | 8 | 143 | |
| Melanie Ongchin | 51 | 16 | 12 | 90 | 14 | 162 | |
| Li Zhou | 55 | 15 | 10 | 73 | 13 | 215 |
All Works
Loading papers...